
SciSparc Ltd. ( ($SPRC) ) has issued an update. SciSparc Ltd. is undergoing a strategic transformation toward Agentic AI-powered technologies, focusing on cybersecurity and finance, while its subsidiary NeuroThera advances
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SPRC | SciSparc Ltd. | 0.18 | -12.76 | -98.58% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.18 | -98.58% |

SciSparc Ltd. ( ($SPRC) ) has issued an update. SciSparc Ltd. is undergoing a strategic transformation toward Agentic AI-powered technologies, focusing on cybersecurity and finance, while its subsidiary NeuroThera advances

This filing relates to the offer and sale from time to time by the selling stockholders of up to 76.81M ordinary shares. The company is not selling any shares under

SciSparc Ltd. ( ($SPRC) ) has provided an update. On November 3, 2026, SciSparc Ltd. entered into a securities purchase agreement with an institutional investor for convertible promissory notes totaling

SciSparc Ltd. ( ($SPRC) ) has shared an announcement. On October 26, 2026, SciSparc Ltd. entered into an inducement letter with investor L.I.A Pure Capital Ltd. to amend existing warrants

TEL AVIV, Israel, October 26th, 2026, FinanceWire SciSparc Ltd. (Nasdaq:SPRC) (“Company” or “SciSparc”), announced that it will shift its strategic focus toward Agentic AI-powered technologies, including cybersecurity and finance technologies.

An announcement from SciSparc Ltd. ( ($SPRC) ) is now available. SciSparc Ltd. reported on October 22, 2026 that subsidiary NeuroThera Labs has advanced its FDA-approved Phase IIb trial of

An announcement from SciSparc Ltd. ( ($SPRC) ) is now available. On October 15, 2026, SciSparc Ltd. entered into an inducement agreement with L.I.A. Pure Capital Ltd., the holder of

SciSparc Ltd. ( ($SPRC) ) just unveiled an announcement. SciSparc Ltd. said on Oct. 15, 2026, that it is shifting its strategic focus toward Agentic AI-powered technologies, initially targeting applications

SciSparc (SPRC)announced that it will shift its strategic focus toward Agentic AI-powered technologies, including cybersecurity and finance technologies. Building on its previously announced decision on July 27 to target the

SciSparc Ltd. ( ($SPRC) ) has shared an update. On October 7, 2026, SciSparc reported that NeuroThera’s majority-owned subsidiary CliniQuantum achieved a major computational milestone using a GPU-accelerated quantum-simulation platform.
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.